Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers

Molecular and Cellular Proteomics

Volumn 8, Issue 6, 2009, Pages 1338-1349

  Gu, Jiayin ^a,b   Pauer, Gayle J T ^a   Yue, Xiuzhen ^a   Narendra, Umadevi ^a   Sturgill, Gwen M ^c   Bena, James ^a   Gu, Xiaorong ^a   Peachey, Neal S ^a,c,d   Salomon, Robert G ^b   Hagstrom, Stephanie A ^a,d   Crabb, John W ^a,b,c,d   Barnhart, David ^e   Dupps, William J ^e   Gutman, Froncie A ^e   Kaiser, Peter K ^e   Lewis, Hilel ^e   Gans, Richard E ^e   Jeng, Bennie H ^e   Kosmorsky, Gregory S ^e   Krueger, Ronald R ^e   Laurenzi, Ann ^e   Langston, Roger H S ^e   Rockwood, Edward J ^e   Sax, William E ^e   Schachat, Andrew P ^e   Sears, Jonathan E ^e   Singh, Rishi ^e   Smith, Scott D ^e   Toabe, Mindy ^e   Traboulsi, Elias I ^e   Waheed, Nadia ^e   Wilson, Steven E ^e   Yaniglos, Stacia S ^e   Bala, Elisa ^e   Bamba, Sonya ^e   Crowe, Sue ^e   Nerone, Patrice ^e   Ruez, Tiffany ^e   Simpson, Ellen ^e   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE RELATED MACULOPATHY SUSCEPTIBILITY 2; AUTOANTIBODY; BIOLOGICAL MARKER; CARBOXYETHYLPYRROLE; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; DOCOSAHEXAENOIC ACID; HIGH TEMPERATURE REQUIREMENT FACTOR A1; LIPID; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOMICS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATION; PLASMA; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEOMICS; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; VISUAL IMPAIRMENT;

AGING; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOME; HUMANS; MACULAR DEGENERATION; POLYMORPHISM, GENETIC; PROTEINS; PROTEOME; SERINE ENDOPEPTIDASES;

EID: 67650519801     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M800453-MCP200     Document Type: Article

References (41)

1. Jager, R. D., Mieler, W. F., and Miller, J. W. (2008) Age-related macular degeneration. N. Engl. J. Med. 358, 2606-2617
2. Age-Related Eye Disease Study Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 119, 1417-1436
3. Friedman, D. S., O'Colmain, B. J., Munoz, B., Tomany, S. C., McCarty, C., de Jong, P. T., Nemesure, B., Mitchell, P., and Kempen, J. (2004) Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 122, 564-572
4. Edwards, A. O., Ritter, R., III, Abel, K. J., Manning, A., Panhuysen, C., and Farrer, L. A. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308, 421-424 (Pubitemid 40530082)
5. Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., Smith, R. J., Silvestri, G., Russell, S. R., Klaver, C. C., Barbazetto, I., Chang, S., Yannuzzi, L. A., Barile, G. R., Merriam, J. C., Smith, R. T., Olsh, A. K., Bergeron, J., Zernant, J., Merriam, J. E., Gold, B., Dean, M., and Allikmets, R. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 102, 7227-7232
6. Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., Schnetz-Boutaud, N., Agarwal, A., Postel, E. A., and Pericak-Vance, M. A. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419-421 (Pubitemid 40530081)
7. Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J. Y., Sackler, R. S., Haynes, C., Henning, A. K., Sangiovanni, J. P., Mane, S. M., Mayne, S. T., Bracken, M. B., Ferris, F. L., Ott, J., Barnstable, C., and Hoh, J. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389 (Pubitemid 40530070)
8. Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., Barile, G. R., Smith, R. T., Hageman, G. S., Dean, M., and Allikmets, R. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 38, 458-462
9. Yates, J. R., Sepp, T., Matharu, B. K., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Hayward, C., Morgan, J., Wright, A. F., Armbrecht, A. M., Dhillon, B., Deary, I. J., Redmond, E., Bird, A. C., and Moore, A. T. (2007) Complement C3 variant and the risk of age-related macular degeneration. N. Engl. J. Med. 357, 553-561
10. Maller, J. B., Fagerness, J. A., Reynolds, R. C., Neale, B. M., Daly, M. J., and Seddon, J. M. (2007) Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat. Genet. 39, 1200-1201
11. Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., Salomon, R. G., and Hollyfield, J. G. (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 99, 14682-14687
12. Hageman, G. S., Luthert, P. J., Victor Chong, N. H., Johnson, L. V., Anderson, D. H., and Mullins, R. F. (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20, 705-732
13. Johnson, L. V., Ozaki, S., Staples, M. K., Erickson, P. A., and Anderson, D. H. (2000) A potential role for immune complex pathogenesis in drusen formation. Exp. Eye Res. 70, 441-449
14. Seddon, J. M., Willett, W. C., Speizer, F. E., and Hankinson, S. E. (1996) A prospective study of cigarette smoking and age-related macular degeneration in women. J. Am. Med. Assoc. 276, 1141-1146
15. Gu, X., Meer, S. G., Miyagi, M., Rayborn, M. E., Hollyfield, J. G., Crabb, J. W., and Salomon, R. G. (2003) Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J. Biol. Chem. 278, 42027-42035
16. Ebrahem, Q., Renganathan, K., Sears, J., Vasanji, A., Gu, X., Lu, L., Salomon, R. G., Crabb, J. W., and Anand-Apte, B. (2006) Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: implications for age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 103, 13480-13484
17. Renganathan, K., Ebrahem, Q., Vasanji, A., Gu, X., Lu, L., Sears, J., Salomon, R. G., Anand-Apte, B., and Crabb, J. W. (2008) Carboxyethylpyrrole adducts, age-related macular degeneration and neovascularization. Adv. Exp. Med. Biol. 613, 261-267
18. Hollyfield, J. G., Bonilha, V. L., Rayborn, M. E., Yang, X., Shadrach, K. G., Lu, L., Ufret, R. L., Salomon, R. G., and Perez, V. L. (2008) Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 14, 194-198
19. Fritsche, L. G., Loenhardt, T., Janssen, A., Fisher, S. A., Rivera, A., Keilhauer, C. N., and Weber, B. H. (2008) Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat. Genet. 40, 892-896
20. Rivera, A., Fisher, S. A., Fritsche, L. G., Keilhauer, C. N., Lichtner, P., Meitinger, T., and Weber, B. H. (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum. Mol. Genet. 14, 3227-3236
21. Jakobsdottir, J., Conley, Y. P., Weeks, D. E., Mah, T. S., Ferrell, R. E., and Gorin, M. B. (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26. Am. J. Hum. Genet. 77, 389-407
22. Maller, J., George, S., Purcell, S., Fagerness, J., Altshuler, D., Daly, M. J., and Seddon, J. M. (2006) Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat. Genet. 38, 1055-1059
23. Yang, Z., Camp, N. J., Sun, H., Tong, Z., Gibbs, D., Cameron, D. J., Chen, H., Zhao, Y., Pearson, E., Li, X., Chien, J., Dewan, A., Harmon, J., Bernstein, P. S., Shridhar, V., Zabriskie, N. A., Hoh, J., Howes, K., and Zhang, K. (2006) A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314, 992-993
24. Dewan, A., Liu, M., Hartman, S., Zhang, S. S., Liu, D. T., Zhao, C., Tarn, P. O., Chan, W. M., Lam, D. S., Snyder, M., Barnstable, C., Pang, C. P., and Hoh, J. (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314, 989-992
25. Gu, X., Sun, M., Gugiu, B., Hazen, S., Crabb, J. W., and Salomon, R. G. (2003) Oxidatively truncated docosahexaenoate phospholipids: total synthesis, generation, and peptide adduction chemistry. J. Org. Chem. 68, 3749-3761
26. Fliesler, S. J., and Anderson, R. E. (1983) Chemistry and metabolism of lipids in the vertebrate retina. Prog. Lipid Res. 22, 79-131
27. Renganathan, K., Sun, M., Darrow, R., Shan, L., Gu, X., Salomon, R. G., Hazen, S., Organisciak, D., and Crabb, J. W. (2003) Light induced protein modifications and lipid oxidation products in rat retina. Investig. Ophthalmol. Vis. Sci. 44, E-abstract 5129
28. Gu, X., Renganathan, K., Grimm, C., Wenzel, A., Salomon, R. G., Rerne, C. E., and Crabb, J. W. (2004) Rapid changes in retinal oxidative protein modifications induced by blue light. Investig. Ophthalmol. Vis. Sci. 45, E-abstract 3474
29. Handa, J. T., Verzijl, N., Matsunaga, H., Aotaki-Keen, A., Lutty, G. A., te Koppele, J. M., Miyata, T., and Hjelmeland, L. M. (1999) Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Investig. Ophthalmol. Vis. Sci. 40, 775-779
30. Ishibashi, T., Murata, T., Hangai, M., Nagai, R., Horiuchi, S., Lopez, P. F., Hinton, D. R., and Ryan, S. J. (1998) Advanced glycation end products in age-related macular degeneration. Arch. Ophthalmol. 116, 1629-1632
31. Ng, K. P., Gugiu, B., Renganathan, K., Davies, M. W., Gu, X., Crabb, J. S., Kim, S. R., Rozanowska, M. B., Bonilha, V. L., Rayborn, M. E., Salomon, R. G., Sparrow, J. R., Boulton, M. E., Hollyfield, J. G., and Crabb, J. W. (2008) Retinal pigment epithelium lipofuscin proteomics. Mol. Cell. Proteomics 7, 1397-1405
32. Hu, D. N., Simon, J. D., and Sarna, T. (2008) Role of ocular melanin in ophthalmic physiology and pathology. Photochem. Photobiol. 84, 639-644
33. Klein, R. (2007) Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol. 14, 184-187
34. Seddon, J. M., Gensler, G., Milton, R. C., Klein, M. L., and Rifai, N. (2004) Association between C-reactive protein and age-related macular degeneration. J. Am. Med. Assoc. 291, 704-710
35. Seddon, J. M., George, S., Rosner, B., and Rifai, N. (2005) Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch. Ophthalmol. 123, 774-782
36. Vine, A. K., Stader, J., Branham, K., Musch, D. C., and Swaroop, A. (2005) Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 112, 2076-2080
37. Boekhoorn, S. S., Vingerling, J. R., Witteman, J. C., Hofman, A., and de Jong, P. T. (2007) C-reactive protein level and risk of aging macula disorder: The Rotterdam Study. Arch. Ophthalmol. 125, 1396-1401
38. McGwin, G., Hall, T. A., Xie, A., and Owsley, C. (2005) The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study. Br. J. Ophthalmol. 89, 1166-1170
39. Wang, J. J., Ross, R. J., Tuo, J., Burlutsky, G., Tan, A. G., Chan, C. C., Favaloro, E. J., Williams, A., and Mitchell, P. (2008) The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study. Ophthalmology 115, 693-699
40. Klein, R., Knudtson, M. D., Klein, B. E., Wong, T. Y., Cotch, M. F., Liu, K., Cheng, C. Y., Burke, G. L., Saad, M. F., Jacobs, D. R., Jr., and Sharrett, A. R. (2008) Inflammation, complement factor H, and age-related macular degeneration: the Multi-Ethnic Study of Atherosclerosis. Ophthalmology 115, 1742-1749
41. Despriet, D. D., Klaver, C. C., Witteman, J. C., Bergen, A. A., Kardys, I., de Maat, M. P., Boekhoorn, S. S., Vingerling, J. R., Hofman, A., Oostra, B. A., Uitterlinden, A. G., Stijnen, T., van Duijn, C. M., and de Jong, P. T. (2006) Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. J. Am. Med. Assoc. 296, 301-309